Orthopediatrics (KIDS) Restructuring Costs (2024 - 2026)
Orthopediatrics (KIDS) posted quarterly Restructuring Costs of $296000.0 for Q4 2025, down 91.9% year-over-year from $3.7 million in Q4 2024, and down 87.1% quarter-over-quarter from $2.3 million in Q3 2025.
Orthopediatrics (KIDS) Restructuring Costs (2024 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has reported Restructuring Costs for 2 consecutive years, with $296000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Restructuring Costs fell 91.9% year-over-year to $296000.0; the TTM figure through Mar 2026 stood at $5.6 million (up 50.58% YoY), while the FY2025 annual figure was $5.6 million, up 53.33% from the prior year.
- Restructuring Costs declined to $296000.0 in Q4 2025 per KIDS's latest filing, from $2.3 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $3.7 million in Q4 2024 and bottomed at $40000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Orthopediatrics | 631.76 Mn | 585.88 Mn | 52.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Dec 31, 2025 | 296,000.00 |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | 3.65 Mn |